United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-433_5c2b8534-f732-425f-83f4-72c59e316ea4
- Product NDC
- 50228-433
- Form
- TABLET
- Composition / generic term
- Naproxen Sodium
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191030
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN SODIUM — 550 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (50228-433-01) · 50228-433-01
- 500 TABLET in 1 BOTTLE (50228-433-05) · 50228-433-05
- 1000 TABLET in 1 BOTTLE (50228-433-10) · 50228-433-10
- 30 TABLET in 1 BOTTLE (50228-433-30) · 50228-433-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →